Sirtex (ASX: SRX) - A therapy going mainstream

Stuart Roberts

Pitt Street Research and NDF Research

Sirtex (ASX: SRX), whose SIR-Spheres product treats liver cancer through localised radiotherapy, had a good FY16, with revenue of A$232m (up 32%) and EBITDA of $70m (up 40%). In constant currency terms revenue rose 17%, in line with dose unit growth, but that was in line with the experience of the last few years. There's potentially much more growth to come because Sirtex has only penetrated about 2% of its addressable market opportunity. At the moment SIR-Spheres are more or less used for 'salvage therapy' of liver cancer patients that have failed everything else. However a succession of large clinical studies aims to show that SIR-Spheres are useful at an earlier stage of treatment. The first of these, called SIRFLOX, has generated early data showing that SIR-Spheres can keep tumours in the liver from growing (called 'Progression-Free Survival) for a median 20.5 months versus only 12.6 months for untreated patients. There's more data from SIRFLOX to come, and three other large studies read out some data in 2017. If the data is any good then Sirtex can reasonably go 'mainstream'.


Stuart Roberts
Founder and Senior Analyst
Pitt Street Research and NDF Research

I am an equity research professional who worked in stockbroking from 2001 to 2015. After 15 months doing investor relations I returned to equity research with the founding of NDF Research. With Marc Kennis I founded Pitt Street Research in July 2018.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.